Needham analysts say that new voices on the patient-monitoring company’s board, after a proxy battle, could catalyze the sale of the audio unit, even as Masimo pursues its consumer healthcare strategy.
Needham analysts say that new voices on the patient-monitoring company’s board, after a proxy battle, could catalyze the sale of the audio unit, even as Masimo pursues its consumer healthcare strategy.